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TRPV2 is critical for the maintenance of cardiac
structure and function in mice
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The heart has a dynamic compensatory mechanism for haemodynamic stress. However, the
molecular details of how mechanical forces are transduced in the heart are unclear. Here we
show that the transient receptor potential, vanilloid family type 2 (TRPV2) cation channel is
critical for the maintenance of cardiac structure and function. Within 4 days of eliminating
TRPV2 from hearts of the adult mice, cardiac function declines severely, with disorganization
of the intercalated discs that support mechanical coupling with neighbouring myocytes and
myocardial conduction defects. After 9 days, cell shortening and Ca2þ handling by single
myocytes are impaired in TRPV2-deﬁcient hearts. TRPV2-deﬁcient neonatal cardiomyocytes
form no intercalated discs and show no extracellular Ca2þ -dependent intracellular Ca2þ
increase and insulin-like growth factor (IGF-1) secretion in response to stretch stimulation.
We further demonstrate that IGF-1 receptor/PI3K/Akt pathway signalling is signiﬁcantly
downregulated in TRPV2-deﬁcient hearts, and that IGF-1 administration partially prevents
chamber dilation and impairment in cardiac pump function in these hearts. Our results
improve our understanding of the molecular processes underlying the maintenance of cardiac
structure and function.
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M
echanical forces provide essential physiological infor-
mation for homeostatic regulation and functional
adaptation at the levels of cells and organs1. In
cardiovascular systems, cellular mechanical responses to
haemodynamic stress are crucial for normal cardiac function,
and affect both the physiological and the pathological growth of
the heart2,3. More speciﬁcally, an increased cardiac workload
resulting from exercise, pregnancy or postnatal growth promotes
the physiological growth of the heart, whereas chronic
hypertension can cause pathological hypertrophy3. Atrophy of
the heart is a complication of protracted bed rest, prolonged
weightlessness during space travel, and mechanical unloading
with a ventricular assist device3. Despite the obvious inﬂuence of
mechanical load on cardiac structure and function, the molecular
details of the myocardial mechanotransduction required to
maintain cardiac structure and function have remained unclear.
The heart is a functional syncytium composed of terminally
differentiated myocytes specialized for excitation–contraction
(E–C) coupling3. Individual cardiomyocytes are electrically and
mechanically coupled at their termini, where highly organized
cell–cell junctions known as intercalated discs are located4–6. The
structure of intercalated discs is known to be remodelled in
response to haemodynamic stress7. High wall stress increases the
myocardial contractile force exerted as a result of cardiac
hypertrophy, and the intercalated disc structure has to be
optimized for physical robustness to adapt to this force3. By
contrast, mechanical unloading causes cardiac atrophy,
accompanied by disorder in the intercalated disc structure7–10.
In addition, human cardiomyopathies have been associated with
mutations in genes encoding components of intercalated
discs, involved in mechanical coupling, and studies in mice and
humans have suggested a connection between faulty myocardial
mechanical coupling mechanisms and heart disease11–15.
Flexibility in cardiac adaptation to haemodynamic stress
probably requires the maintenance of intercalated disc structure
and function by continuous monitoring of the mechanical stress
at intercalated discs. Therefore, we hypothesized that cardiac
mechanoreceptors at intercalated discs detect mechanical stress in
the heart, maintaining myocardial structure and function in
response to haemodynamic stress through the mechanical
feedback system in cardiomyocytes.
Members of the transient receptor potential (TRP) cation
channel family are potential candidates for the mechanoreceptors
responding to tension, ﬂow or changes in cell volume16.
Previously, we reported that recombinant TRP, vanilloid
family type 2 (TRPV2) can be activated by hypotonicity- and
stretch-induced mechanical stimulation in ectopic expression
systems17,18. Interestingly, TRPV2 is highly localized to
mammalian cardiac intercalated discs, and its increased
expression at the sarcolemma is observed in dystrophic human
patients and animal models deﬁcient in dystrophin or
d-sarcoglycan17. To elucidate the physiological role of cardiac
TRPV2, we generated temporally controlled cardiac-speciﬁc
TRPV2-deﬁcient mice. Cardiac-speciﬁc TRPV2 elimination led
to a severe decline in the heart’s pump function with the
disorganization of the intercalated disc structure, conduction
defects and accelerated mortality. TRPV2-deﬁcient neonatal
cardiomyocytes formed no intercalated discs and showed no
extracellular Ca2þ -dependent intracellular Ca2þ increase and
IGF-1 secretion after stretch stimulation. TRPV2-deﬁcient
hearts showed downregulation of IGF-1 receptor/PI3K/Akt
signalling. In addition, IGF-1 administration partially prevented
chamber dilation and improved cardiac pump function in
TRPV2-deﬁcient hearts. These results suggest an indispensable
role for TRPV2 in the maintenance of cardiac structure and
function.
Results
Generation of cardiac-speciﬁc TRPV2-deﬁcient mice.
Initially, mice carrying a TRPV2ﬂox/ﬂox allele were generated by
ﬂanking exon 4 of the TRPV2 gene with two loxP sequences
(Supplementary Fig. 1). Excision of this segment resulted in a
frameshift mutation downstream of the deletion sites. Translation
from the ﬁrst ATG gave rise to a short, 92 amino-acid (aa)
product containing 62 aa of the original TRPV2 protein; however,
most of the TRPV2 channel structure was lost after Cre-mediated
recombination. We crossed mice bearing the TRPV2ﬂox/ﬂox
allele with a transgenic line (MerCreMer) expressing Cre
recombinase under the control of the a-myosin heavy chain
promoter in a tamoxifen-inducible cardiomyocyte-speciﬁc
manner19 to produce TRPV2ﬂox/ﬂox;MerCreMerþ / mice. To
account for the deleterious effect of potential nonspeciﬁc Cre
recombinase-mediated cardiotoxicity20, we used TRPV2ﬂox/þ ;
MerCreMerþ / and TRPV2ﬂox/ﬂox;MerCreMer / littermates
as age-matched controls, from which TRPV2ﬂox/ﬂox;
MerCreMerþ / mice were indistinguishable in appearance.
The TRPV2ﬂox/ﬂox;MerCreMerþ / mice were genotyped by
PCR using primers for Cre-loxP sites and Cre recombinase
(Fig. 1a and Supplementary Fig. 1). In adult TRPV2ﬂox/ﬂox;
MerCreMerþ / mice treated with tamoxifen for 3 days (daily
dose of 8mg kg 1), we conﬁrmed successful Cre recombination
by PCR ampliﬁcation of cardiac genomic DNA, to detect the
deleted allele (Fig. 1b). Consistently, the expression of TRPV2
messenger RNA was dramatically suppressed in the hearts of
TRPV2-deﬁcient mice on day 3 (Fig. 1c). There was an B95%
reduction in TRPV2 protein in membrane extracts of cardiac
muscle from these mice after 4 days of tamoxifen treatment
(Fig. 1d). Consistently, the TRPV2 protein was also not detectable
by immunoﬂuorescent staining at intercalated discs in the hearts
of these mice, although TRPV2 was highly localized to
intercalated discs in control mice (Fig. 1e). Hereafter, in this
study, we treated TRPV2ﬂox/ﬂox;MerCreMerþ / , TRPV2ﬂox/þ ;
MerCreMerþ / and TRPV2ﬂox/ﬂox;MerCreMer / mice with
8mg kg 1 per day tamoxifen or vehicle for 4 consecutive days,
then carried out analyses at different time points.
The chamber dilation in TRPV2-deﬁcient hearts. Parafﬁn
sections from TRPV2-deﬁcient hearts were treated with Masson’s
trichrome stain and analysed histologically. After 4 days of
tamoxifen treatment, hearts from TRPV2ﬂox/ﬂox;MerCreMerþ /
mice were morphologically normal with no incremental changes
in the heart weight/body weight ratio or the cross-sectional area
of the cardiomyocytes (Fig. 2a–d). However, 9 days after the onset
of tamoxifen treatment, the chambers of the hearts from these
mice were enlarged, as seen in the ﬁnal phase of dilated cardio-
myopathy (Fig. 2a). This dilation differed from ventricular
hypertrophy as the ventricle wall was not thickened. As evidence
of this, within 10 days of the onset of tamoxifen administration,
the heart weight/body weight ratio and cardiomyocyte cross-
sectional area in TRPV2-deﬁcient hearts were comparable with
those of control mice (Fig. 2b,c). In addition, the cardiomyocytes
of TRPV2-deﬁcient mice showed no cellular degeneration or
intermuscular ﬁbrosis (Fig. 2d). Whereas the cell–cell interfaces
forming intercalated discs ran perpendicular to the muscle ﬁbres
in the hearts of TRPV2ﬂox/ﬂox;MerCreMerþ / control mice
treated only with vehicle, in hearts treated with tamoxifen for
9 days, the contact areas between cells corresponding to inter-
calated discs were expanded, extended and irregularly shaped
(Fig. 2e). Thus, it is possible that the chamber dilation in TRPV2-
deﬁcient hearts on day 9 was associated with cellular elongation
resulting from the disorganization of the intercalated disc struc-
ture. Surprisingly, about 70% of TRPV2ﬂox/ﬂox;MerCreMerþ /
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mice died within 10 days of the onset of tamoxifen treatment,
suggesting an indispensable role for TRPV2 in the working heart
(Fig. 2f).
The cardiovascular function in TRPV2-deﬁcient mice. Echo-
cardiography revealed a severe decline in fractional shortening
and an increased left ventricular diastolic dimension 4 days
after the start of tamoxifen treatment (Fig. 3a,b). Cardiac
dysfunction was not observed in tamoxifen-treated TRPV2ﬂox/þ ;
MerCreMerþ / mice (hetero knockout (KO) mice) for 4 days
(Supplementary Fig. 2). Therefore, the cardiac dysfunction seen
in TRPV2-deﬁcient mice (homo KO mice) is not due to side
effects associated with the overexpression of Cre recombinase or
tamoxifen administration.
Figure 3c,d show that aortic blood pressure also gradually
dropped in TRPV2-deﬁcient mice after 3 days of tamoxifen
treatment, although the heart rate did not change (Fig. 3e).
Notably, the time course of blood pressure decline closely
paralleled the time course of Cre-loxP recombination in
tamoxifen-treated TRPV2ﬂox/ﬂox;MerCreMerþ / mice (Fig. 1b,c).
Therefore, the rapid reduction in blood pressure appeared to result
from the severe decline in cardiac pump function following the
elimination of TRPV2. This suggests that TRPV2 is critical for
cardiac function under basal conditions.
The disordered intercalated discs in TRPV2-deﬁcient hearts.
Although the gross morphology of the hearts of tamoxifen-treated
TRPV2ﬂox/ﬂox;MerCreMerþ / mice after 4 days was effectively
normal (Fig. 2a), the ultrastructure of the intercalated discs was
already dramatically disrupted (Fig. 4a), showing extensive inter-
digitation, irregular shapes, lacunae and widened spaces at the sites
of myoﬁbril attachment. Immunostaining for N-cadherin and
b-catenin, components of adherens junctions4–6, showed a denser
localization at cell–cell interfaces in TRPV2-deﬁcient hearts
compared with vehicle controls (Fig. 4b). The structural
abnormality of intercalated disc architecture seen in TRPV2ﬂox/ﬂox;
MerCreMerþ / hearts is considered synonymous with impaired
mechanical interactions with neighbouring myocytes15. These
observations suggest that the severe decline in cardiac pump
function was associated with the structural disruption of
intercalated discs and adherens junctions, suggesting that
mechanical coupling at these sites is under the control of TRPV2.
TRPV2 elimination affects myocardial electrical coupling.
A number of cardiac disorders have been described in which
disruption of the intercalated disc structure signiﬁcantly affects
electrical coupling4. In TRPV2-deﬁcient myocytes, 4 days after
the onset of tamoxifen treatment, the gap junction protein
connexin 43 showed diffuse localization in the intercalated discs
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Figure 1 | Generation of temporally controlled cardiac-speciﬁc TRPV2-deﬁcient mice. (a) Genotyping of TRPV2ﬂox/ﬂox;MerCreMerþ/ mice using tail
genomic DNA. (b) Conﬁrmation of Cre recombination by PCR of cardiac genomic DNA. (c) TRPV2 messenger RNA expression conﬁrmed by RT–PCR,
using b-actin as an internal control gene (n¼ 3 mice per group). Data are mean±s.e.m. *Po0.05 versus non-treated age-matched TRPV2ﬂox/ﬂox;
MerCreMer/ (TRPV2ﬂox/ﬂox) mice. (d) Expression of TRPV2 protein in heart and kidney from tamoxifen-treated and -untreated TRPV2ﬂox/ﬂox or
TRPV2ﬂox/ﬂox;MerCreMerþ/ (TRPV2ﬂox/ﬂox; Creþ / ) mice, using caveolin 3 as an internal control for hearts. Membrane extracts (10mg per lane)
were subjected to immunoblotting. (See full blots with marker position in Supplementary Fig. 6). (e) Triple staining of left ventricle sections with
anti-TRPV2 antibody (green), phalloidin (red) and DAPI (blue). Scale bar, 100mm. Arrows, intercalated discs.
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and its expression spread along the sarcolemma over time
(Fig. 5a). Typical electrocardiograms obtained by telemetry
showed no abnormalities over the ﬁrst 4 days of tamoxifen
administration (Fig. 5b); however, after 5 days, QRS complexes
time-dependently widened (Supplementary Fig. 3), and 1 week
after the onset of tamoxifen treatment, TRPV2-deﬁcent hearts
showed intraventricular conduction delays (Fig. 5b). As this
phenomenon occurred several days after a drop in blood pressure
was seen (Fig. 3c), it is likely that the disorganization of the
intercalated disc architecture after the loss of TRPV2 had an
indirect effect on electrical coupling with neighbouring myocytes.
TRPV2-deﬁcient cardiomyocytes are fully functional.
Abnormal Ca2þ handling by cardiomyocytes is a central cause of
contractile dysfunction3. To investigate the E–C coupling of
TRPV2-deﬁcient myocytes, we analysed contractility and Ca2þ
handling in single cardiomyocytes from tamoxifen-treated and -
untreated TRPV2ﬂox/ﬂox;MerCreMerþ / mice. Despite severe
cardiac dysfunction, single myocytes isolated from these mice
treated with tamoxifen for 4 days showed no abnormalities in cell
morphology and shortening (Fig. 6a,b) or intracellular Ca2þ
transients evoked by electrical stimulation (Fig. 6c), suggesting
that the ablation of TRPV2 causes no signiﬁcant change in
intracellular Ca2þ handling for E–C coupling. By contrast, after 9
days of tamoxifen treatment, the isolated TRPV2-deﬁcient
cardiomyocytes showed an elongated morphology (Fig. 6a).
These myocytes showed signiﬁcantly impaired contractility
(Fig. 6b) and Ca2þ cycling (Fig. 6c), compared with vehicle-
treated control cells, and electrically evoked Ca2þ transient peaks
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Figure 2 | Morphological changes and survival in TRPV2-deﬁcient mice. TRPV2ﬂox/ﬂox;MerCreMer/ (TRPV2ﬂox/ﬂox) and TRPV2ﬂox/ﬂox;MerCreMerþ
(TRPV2ﬂox/ﬂox;Creþ / ) mice, treated with tamoxifen or vehicle, were analysed on day 4 and day 9. (a) Cardiac morphology. Scale bar, 5mm. (b) Heart
weight (HW)/body weight (BW) ratio. Data are mean±s.e.m. (n¼ 22–35 hearts per group) (c) Cross-sectional areas from parafﬁn sections of left
ventricles. Data are mean±s.e.m. (n¼ 122–153 cells from three hearts per group) (d) Masson’s trichrome staining of the left ventricle. Scale bar, 50mm
(e) Double staining with anti-vinculin antibody (green) and DAPI (blue). Scale bar, 100 mm. Arrowheads, intercalated discs. (f) Survival probabilities
(n¼ 55–85 per group). *Po0.05 versus TRPV2ﬂox/ﬂox;Creþ / mice treated with vehicle, by log-rank tests.
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TRPV2ﬂox/ﬂox;Creþ / mouse hearts. Scale bar, 75mm. Arrows, intercalated discs.
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with reduced amplitude and a slow decay speed (Fig. 6d,e). In
addition, the Ca2þ content of the myocyte sarcoplasmic
reticulum was reduced (Fig. 6f), although intracellular free
Ca2þ concentrations under basal conditions were in line with
the controls.
The subcellular structure of cardiomyocytes and the localiza-
tion of Ca2þ regulatory proteins are well suited to their cellular
functions21. In cardiomyocytes, Ca2þ release for contraction
occurs at distinct structures (dyads) along T-tubules, which are
critical for efﬁcient E–C coupling22. In the dyad space in control
vehicle-treated hearts, L-type Ca2þ channels and Naþ /Ca2þ
exchangers were localized in T-tubules, and ryanodine receptors
were located on sarcoplasmic reticulum membranes, so that these
immunoﬂuorescence signals appeared as well-ordered patterns
(Fig. 7a). In TRPV2ﬂox/ﬂox;MerCreMerþ / mice treated with
tamoxifen for 4 days, the key Ca2þ regulatory proteins in
cardiomyocyte E–C coupling (that is, L-type Ca2þ channels,
ryanodine receptors, and Naþ /Ca2þ exchangers) were normally
expressed, and localized in T-tubules and sarcoplasmic reticulum
membranes, as in vehicle controls, suggesting normal Ca2þ
handling in the cardiomyocytes (Fig. 7a,b). The myoﬁlament
structures were normal in these tamoxifen-treated mice for 4 days
(Fig. 7c). Thus, the main cause of the rapid and severe decline in
cardiac pump function in TRPV2-deﬁcient hearts was not
abnormal Ca2þ handling affecting myocyte E–C coupling or
disorganization of contractile ﬁlaments.
Abnormal Ca2þ handling in TRPV2-deﬁcient myocytes. In
TRPV2ﬂox/ﬂox;MerCreMerþ / hearts, 9 days after the onset of
tamoxifen treatment the subcellular localization of L-type Ca2þ
channels, ryanodine receptors and Naþ /Ca2þ exchangers was
abnormal, representing a defect in intracellular Ca2þ handling
(Fig. 7a), although the levels of expression of these Ca2þ
regulatory proteins were similar to controls (Fig. 7b). It was
possible that T-tubules and dyad structures were disordered in
TRPV2-deﬁcient hearts by day 9. In isolated cardiomyocytes at
this stage, RyR activity was not only signiﬁcantly lower (Fig. 6c,d),
but the reaction area of Ca2þ sparks elicited by electrical sti-
mulation was also reduced and showed subcellular heterogeneity
(Supplementary Fig. 4). TRPV2-deﬁcient myocytes on day 9 also
showed extensive disorganization of the myoﬁlaments needed to
generate force (Fig. 7c). At this later stage, TRPV2-deﬁcient
myocytes showed impaired Ca2þ handling (Fig. 6b–f and
Supplementary Fig. 4) and disorganization of the contractile
cytoskeletal apparatus (Fig. 7c). Thus, eliminating TRPV2 not
only led to a rapid and severe decline in normal cardiac pump
function, but also resulted in a subsequent cellular dysfunction in
individual myocytes.
Characterization of TRPV2-deﬁcient neonatal cardiomyocytes.
Intra-, inter- and extracellular mechanical forces play vital roles
in the differentiation and maturation of cardiomyocytes, both in
in vivo and in vitro1–3. In particular, the formation of mature
intercalated discs is important during development for directing
myoﬁbrogenesis, appropriate Ca2þ handling for E–C coupling
and differentiation into synchronously beating myocytes6. In
cultured newborn cardiomyocytes, we were able to follow the
formation of intercalated discs and the reorganization of
myoﬁbrils with time in myocytes isolated by enzymatic
dissociation from neonatal heart tissue23. When we examined
the formation of intercalated discs in cultured neonatal
cardiomyocytes, by staining for the gap junction protein,
connexin 43, and N-cadherin (Fig. 8a, upper and middle, ﬁrst
three panels), we observed that the intercalated disc structures at
cell–cell interfaces showed many zigzags, sharp turns and a high
degree of convolution. In control cardiomyocytes isolated from
TRPV2ﬂox/ﬂox;MerCreMer / with or without tamoxifen
treatment or TRPV2ﬂox/ﬂox;MerCreMerþ / mice cultured
without tamoxifen (Fig. 8a, all panels except for right column),
we observed well-developed sarcomeres, typical localization of
connexin 43 and N-cadherin to intercalated discs at cell–cell
interfaces and synchronously beating myocytes. In these
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Figure 5 | Cardiac conduction defects after TRPV2 elimination. (a) Change in connexin 43 localization in TRPV2ﬂox/ﬂox;Creþ / hearts after tamoxifen
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cardiomyocytes, NCX1 was highly expressed at the cell surface
and at intercalated areas, indicating their maturation and
differentiation into synchronously beating myocytes (Fig. 8a,
ﬁrst three bottom panels). By contrast, TRPV2-deﬁcient myocytes
cultured with 0.2 mgml 1 tamoxifen for 48 h formed no
intercalated discs between neighbouring cells, and showed
aberrant intracytoplasmic accumulation of connexin 43,
internally defuse N-cadherin, and reduced expression of NCX1
(Fig. 8a, right panels). Although we observed spontaneous weak
beating in TRPV2-deﬁcient myocytes, it was not synchronous.
Previously, we reported that recombinant TRPV2 in Chinese
hamster ovary cells could be activated by stretch-induced
mechanical stimulation17,18. We investigated whether neonatal
cardiomyocytes showed an intracellular Ca2þ increase after
stretch stimulation dependent upon TRPV2. In TRPV2ﬂox/ﬂox;
MerCreMerþ / myocytes untreated with tamoxifen, an
extracellular Ca2þ -dependent intracellular Ca2þ increase was
detected after stretch stimulation, which was blocked by
inhibitors of stretch-activated channels, Gd3þ or ruthenium
red (RR) (Fig. 8b–d). Although RR is known to block RyR, its
effect is not permanent, so using a bath application should limit
its effects to plasma membrane channels24. By contrast, no
stretch-evoked Ca2þ increase was observed in tamoxifen-treated
myocytes. In addition, we conﬁrmed the stretch-evoked Ca2þ
increase in HEK293 cells expressing TRPV2 and the blockade of
this response by Gd3þ or RR (Fig. 8e). These results indicate that
TRPV2 is a key molecule in the stretch-induced Ca2þ response
of cardiomyocytes. Interestingly, the formation of intercalated
discs and the maturation into cardiomyocytes showing the
synchronized beating and alignment of myoﬁlaments seen in
vehicle-treated TRPV2ﬂox/ﬂox;MerCreMerþ / myocytes were
disturbed in the presence of RR at the same level as in TRPV2-
deﬁcient myocytes (Fig. 8f). Taken together, these ﬁndings
suggest that TRPV2 activation is required for the formation of
intercalated discs connecting neighbouring myocytes and their
maturation into synchronously beating myocytes.
Stretch-dependent TRPV2 activation controls IGF-1 secretion.
Substantial evidence from genetic mouse models has demon-
strated the critical role of the IGF-1 receptor/PI3K/Akt pathway
in maintaining physiological cardiac morphology and function25.
Surprisingly, the connection with neighbouring myocytes and
sarcomere orientation was maintained in TRPV2-deﬁcient
myocytes, when IGF-1 was added to cultures (Fig. 9a).
Therefore, we measured IGF-1 secretion from cardiomyocytes
in culture in response to cyclic stretch stimulation at 1Hz for
30min. IGF-1 secretion was markedly elevated in control
+ Tamoxifen (4 days) + Tamoxifen (9 days)Vehicle (4 days)
10
15
20
+Tam 4d
+Tam 9d
Vehicle 4d
TRPV2 flox/flox;Cre+/–
+Tam 4d
+Tam 9d
Vehicle 4d
TRPV2 flox/flox;Cre+/–
1.02
1.04
1.06
1.08
1.1
F/
F0
*
*
*
0
0 1 2 3 4 5
5
Sh
or
te
ni
ng
 (%
 le
ng
th)
Frequency (Hz)
*
0 200 400 600 800 1,000
1
Time T (ms)
0.1 350
*
0.25 Caffeine 10 mM
0
0.02
0.04
0.06
0.08
N
or
m
al
iz
ed
 a
m
pl
itu
de
*
0
50
100
150
200
250
300
Ti
m
e 
co
ns
ta
nt
 τ 
(m
s)
*
0
0.05
0.1
0.15
0.2
N
or
m
al
iz
e
d 
Δr
a
tio
*
4 d
+ Tamoxifen
Ve
hic
le
Ve
hic
le
Ve
hic
le+ Tamoxifen + Tamoxifen
9 d4 d4 d 9 d4 d4 d 9 d4 d
TRPV2 flox/flox;Cre +/–
Figure 6 | Cardiomyocyte contractility and Ca2þ handling by isolated cells from TRPV2-deﬁcient hearts. (a) Morphology of isolated cardiomyocytes.
Scale bar, 50mm. (b) Frequency-dependent shortening of myocytes (n¼ 100, 175, and 58 cells measured from 8, 6 and 3 hearts). (c) Indo-1 ﬂuorescence
in single cardiomyocytes stimulated at 1 Hz (n¼ 28, 18 and 12 cells from 7, 4 and 3 hearts). (d) Peak amplitude of Ca2þ transients. (e) Decay time
constant obtained by ﬁtting the decline phase. (f) Estimation of sarcoplasmic reticulum Ca2þ content. Data are means±s.e.m. *Po0.05 versus vehicle
control.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4932 ARTICLE
NATURE COMMUNICATIONS | 5:3932 | DOI: 10.1038/ncomms4932 | www.nature.com/naturecommunications 7
& 2014 Macmillan Publishers Limited. All rights reserved.
myocytes and was blocked by the inhibitors of stretch-activated
channels, Gd3þ or RR, whereas it was signiﬁcantly reduced in
TRPV2-deﬁcient myocytes (Fig. 9b).
IGF-1 secreted from cardiomyocytes and ﬁbroblast promotes
the cardioprotective response to severe pressure overload by
activating PI3K and its downstream effector Akt26,27. Patients
with heart failure have been reported to have signiﬁcantly lower
IGF-1 levels compared with controls28. In TRPV2ﬂox/ﬂox;
MerCreMerþ / mice treated with tamoxifen for 3 or 4 days,
IGF-1, IGF-1 receptor, PI3Ka and Akt1 expression was
signiﬁcantly reduced (Fig. 9c–f). These observations suggest that
the IGF-1 receptor/PI3K/Akt pathway is downregulated in
TRPV2-deﬁcient hearts.
Effects of IGF-1 administration in TRPV2-deﬁcient hearts. To
investigate whether the reduced IGF-1 signalling seen in TRPV2-
deﬁcient mice represented a signiﬁcant molecular basis for their
observed heart failure phenotype, we treated TRPV2-deﬁcient
mice with recombinant IGF-1. In normal mice, IGF-1
administration for 1 week resulted in an increase in cardiac mass
and heart-to-body weight ratio (Fig. 9g,h). Remarkably, in
TRPV2-deﬁcient mice, administering IGF-1 prevented both the
enlargement of the left ventricular diastolic dimensions and
cardiac dysfunction (Fig. 9i,j). In addition, expression of
IGF-1 receptor, PI3Ka and Akt1 were all signiﬁcantly increased
by the administration of IGF-1 in TRPV2-deﬁcient hearts
(Supplementary Fig. 5). These results suggest that reduced IGF-1
signalling is a major factor in the heart failure observed in
TRPV2-deﬁcient mice. However, IGF-1 administration did not
result in complete recovery, suggesting that other signalling
pathways may also be impaired in TRPV2-deﬁcient hearts.
Discussion
This study has shown a critical role for TRPV2 in the normal
heart. TRPV2 is localized at intercalated discs, which are critical
for detecting the mechanical forces generated by myocyte
contraction. The elimination of TRPV2 from the mouse heart
resulted in severe cardiac dysfunction within a few days (Fig. 3),
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despite no impairment of myocyte contraction or E–C coupling
efﬁciency (Fig. 6). These observations suggest that the functional
integration with neighbouring cardiomyocytes was weakened in
TRPV2-deﬁcient hearts. It seems that cardiomyocytes sense
inadequate functional output at a cellular level and respond by
increasing the number of myoﬁbrillar attachment sites in
intercalated area7. In a failing heart, the elevated expression of
adherens junction proteins and the increase in membrane
convolution and interdigitation between neighbouring
cardiomyocytes seems to lead to a decrease in the ﬂexibility of
the contractile tissue and increased stiffness7. In TRPV2-deﬁcient
hearts, the myoﬁlaments were disassembled at their attachment
sites to intercalated discs (Fig. 4a). The TRPV2-deﬁcient
myocytes did not seem to sense the inadequate functional
output or the severe cardiac dysfunction and therefore might have
difﬁculty maintaining the integrity of their intercalated discs. On
the other hand, cultured neonatal cardiomyocytes from TRPV2-
deﬁcient mice showed impaired formation of intercalated discs
and translocation of connexin 43 and N-cadherin into cell–cell
adhesion sites, and no spontaneous, synchronized beating
(Fig. 8a). The TRPV2 inhibitor, RR, also affected intercalated
disc formation in neonatal cardiomyocytes (Fig. 8f), implicating
TRPV2 activity in the maintenance of intercalated disc integrity
as well as their formation. Further experiments are needed to
elucidate the molecular mechanism involved in maintaining
intercalated disc structure and exactly how this function depends
upon TRPV2.
It is possible that TRPV2 has a pivotal role as an anchoring
protein for myoﬁbrils at intercalated discs, coordinating the
transmission of mechanical forces regardless of its channel
activity. The transmission of the force generated by contracting
myoﬁbrils is mediated by so-called adherens junctions, which are
composed of transmembrane proteins of the cadherin family and
which, in the cytoplasm, are coupled to the contracting
sarcomeres by members of the catenin family7. Reportedly,
TRPV4 associates with adherens junctions via a-catenin in the
human bladder urothelium29. In common with several members
of other TRP subfamilies30, the cytoplasmic region of TRPV2 is
likely to couple to a rigid intracellular structural network and
form ‘mechanosensitive Ca2þ -signalosomes’ at intercalated
discs. If so, eliminating TRPV2 is therefore likely to interrupt
mechanical coupling with neighbouring myocytes at intercalated
discs, causing severe cardiac dysfunction.
In addition, we showed a signiﬁcant reduction of stretch-
dependent IGF-1 secretion in TRPV2-deﬁcient myocytes
(Fig. 9b), and a downregulation of IGF-1 receptor/PI3K/Akt
signalling in TRPV2-deﬁcient hearts (Fig. 9c–f). IGF-1 is
continuously secreted in the normal state and in response to
mechanical stress dependent on the intracellular Ca2þ concen-
tration25,26,31; this in turn modulates myocyte PI3K signalling,
which is involved in myocardial hypertrophy and heart failure25.
It appears that the TRPV2 activation-dependent IGF-1 secretion
of cardiomyocytes controls the equilibrium balance of intra-
cellular IGF-1 receptor/PI3K/Akt signalling in response to
haemodynamic stress. This forms a molecular basis for the
myocyte mechanical feedback mechanism in the normal state and
in response to haemodynamic stress, which is required to
maintain cardiac structure and function. Therefore, loss of
TRPV2 not only leads to a rapid and severe decline in normal
cardiac pump function, but also triggers subsequent cellular
dysfunction in individual myocytes.
TRP channels are unique cellular sensors responding to a wide
variety of extracellular and intracellular signals, including
mechanical and osmotic stress32. The present study shows that
TRPV2 is a candidate molecule for stretch-activated channels in
myocyte intercalated discs, and is crucial for the mechanical
stimulation-dependent Ca2þ signalling of cardiomyocytes.
However, it is unclear whether TRPV2 channels directly
transduce mechanical stimuli or are part of a downstream
signalling pathway, as discussed below. Several regulatory
interactions between TRPV2 cytoplasmic domains and various
signalling molecules have been investigated. Mercado et al.33
proposed that PIP2 is constitutively associated with the
C-terminal domain of TRPV2, promoting its inhibition Ca2þ -
dependently. It is not yet certain that TRPV2 directly senses
membrane lipid stretching through PIP2 breakdown and
diacylglycerol production, as has been shown for other mechano-
sensitive channels34,35. Therefore, to clarify the regulatory
mechanism of TRPV2 activation, further electrophysiological
investigations will be needed in the future.
TRPV2 has been reported to translocate from an intracellular
compartment to the plasma membrane in response to IGF-1 and
intracellular Ca2þ concentration17,36. Therefore, the appropriate
control of these mediators might be needed for the localization of
TRPV2 to the membrane in intercalated discs in working hearts.
It is possible that the transmission and generation of mechanical
force during contraction in response to haemodynamic stress
provides the control for IGF-1 production and intracellular Ca2þ
concentrations, in which TRPV2 plays a pivotal role by
continuously monitoring mechanical stress. TRPV2 activity is
also directly controlled by PI3K activity, and this is independent
of channel translocation to the plasma membrane37. Activation of
PI3K by growth factors results in PIP3 synthesis, by the
phosphorylation of PIP2 (ref. 25). Thus, TRPV2 activity is also
likely to be regulated by the PIP2 content, dependent on PI3K
activity, and interactions with other lipids in intercalated discs.
However, little is known about the lipid composition of
intercalated discs. Taken together, these ﬁndings suggest that
the lipid composition and potentiation of the IGF-1 receptor/
PI3K/Akt signalling cascade in response to haemodynamic stress
are key factors for TRPV2 activation at intercalated discs in the
heart.
This study has identiﬁed a molecular basis for the maintenance
of cardiac structure and function, through myocyte mechanical
feedback systems, in which TRPV2 plays a pivotal role (Fig. 10).
The integrity of intercalated discs has a large impact on force
transmission and generation during muscle contraction, and is
reﬂected in the effect of mechanical feedback on the quality of
myocytes in the heart. Eliminating TRPV2 had no effect on Ca2þ
handling in myocyte E–C coupling (Fig. 6b–f), which is generated
at dyads formed between a T-tubule and the junctional part of the
sarcoplasmic reticulum. It appears that the Ca2þ signalling
Figure 9 | Impairment of stretch-dependent IGF-1 secretion and IGF-1 receptor/PI3K/Akt pathway in TRPV2-deﬁcient yocytes. (a) Isolated
cardiomyocytes from newborn mice cultured with 10mM IGF-1. Scale bar, 100mm. (b) Stretch-dependent IGF-1 secretion by cardiomyocytes. *Po0.05
versus the other groups. Data are means±s.e.m. (c–f) IGF-1, IGF-1 receptor, PI3Ka and Akt expression level in TRPV2-deﬁcient hearts (n¼ 3 mice per group).
*Po0.05 versus non-treated TRPV2ﬂox/ﬂox mice. Data are means±s.e.m. (g) Histological analysis 7 days after onset of IGF-1 administration and
tamoxifen treatment in TRPV2-deﬁcient mice. Scale bar, 5mm. (h) HW/BW ratio. Data are means±s.e.m. (n¼ 5–12 per group) *Po0.05 for tamoxifen-
treated TRPV2ﬂox/ﬂox;Creþ / mice versus IGF-1-treated TRPV2ﬂox/ﬂox;Creþ / mice after 7 days. (i,j) Echocardiographic parameters (n¼ 3 per group).
(i) Data are means±s.e.m. *Po0.05 versus all the other groups. by two-way analysis of variance with Bonferroni’s post hoc test.
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involved in myocyte E–C coupling and the mechanical signal
mediated by TRPV2 are spatially and temporally controlled by
different signals in cardiomyocytes. Further studies might clarify
the molecular mechanism of mechanotransduction mediated by
TRPV2 in cardiomyocytes, and so improve our understanding of
cardiac development and maturation, hypertrophic remodelling
in the heart and the pathophysiology of heart disease.
Recently, Rubinstein et al.38 reported the cardiac function of
TRPV2-KO mice expressing Cre under the control of the
cytomegalovirus promoter generated by Park et al39. They
observed that cardiac function declined in TRPV2-deﬁcient
mice compared with controls, despite no histological
abnormality38. Although there are differences in the severity of
cardiac dysfunction and the depression of myocyte contractility,
these results are consistent with our observations. However, the
construction of their TRPV2-KO mice differed from our model in
the site at which the partial elimination occurred, which
corresponded to the channel pore and carboxy-terminal region
of TRPV2, using a ubiquitous promoter, and the genetic
background of the mice (B6129SF2/J)39. Park et al.39 have
reported that their model was susceptible to perinatal lethality
but displayed normal thermal and mechanical nociception.
They therefore suggested the possibility that compensatory
mechanisms prevented the obvious phenotype of TRPV2-
deﬁcient cells being reﬂected in their KO mice39. On the other
hand, the cardiac-speciﬁc elimination of TRPV2 in this
study affected neither the embryonic development nor the
growth after birth, in the absence of tamoxifen administration.
Taken together, we believe that the acute elimination of TRPV2
function in our model might circumvent any hypothetical
compensatory process.
Methods
Animals. Mice were housed under a 12-h light–dark cycle in a temperature-
controlled environment. All the experiments were performed in male mice aged 10
weeks old (weighing 22–24 g). Littermates were used in this study to randomize
genetic variation. All animal experiments were approved by the Animal Research
Committee of Okayama University (Okayama, Japan), and were performed in
accordance with institutional guidelines.
Generation of TRPV2 conditional KO mice. All experiments requiring gene
recombination in this study were carried out in accordance with the institutional
guideline of Okayama University (Okayama, Japan). Using cloned TRPV2 cDNA
(accession code. NM011706) as a probe, we screened a genomic library constructed
from C57/BL6J mouse DNA. The genomic clone was used to generate the targeting
vector shown in Supplementary Fig. 1, which was linearized for electroporation
into C57/BL6J ES cells. After selection, G418-resistant ES clones were screened for
the presence of the targeted locus by southern blot analysis. Targeted ES cells were
microinjected into Balb/c mouse blastocysts, and germline transmission of the
TRPV2 conditional null alleles was conﬁrmed by southern blotting and PCR
genotyping using genomic DNA extracted from mouse tail veins. We crossed
mice carrying a TRPV2ﬂox allele with transgenic mice (MerCreMer) expressing
tamoxifen-inducible cardiomyocyte-speciﬁc Cre recombinase to produce
TRPV2ﬂox/ﬂox;MerCreMerþ / mice. Germline transmission of TRPV2 conditional
null alleles was conﬁrmed by southern blotting and PCR genotyping using the
primer pair 50-TTAAATGACTTGTGAGGGAGATAGC-30 and 50-CAAGTAACA
CAATCTACCCAAGGTC-30 , yielding 322 (wild-type) and 369 (null allele) bp
products. To induce Cre-mediated recombination, we injected 10-week-old male
TRPV2ﬂox/ﬂox;MerCreMerþ / , TRPV2ﬂox/þ ;MerCreMerþ / and TRPV2ﬂox/ﬂox;
MerCreMer / mice intraperitoneally with 8mg kg 1 tamoxifen (Sigma) once
daily for 4 consecutive days. Tamoxifen injection and subsequent analyses were
performed in a blinded fashion.
Electrocardiography. Transthoracic electrocardiography (ECG) was used to
evaluate cardiac function with the Aplio 300 (Toshiba Medical System) and a
14-MHz transducer. The 10-week-old male mice were anesthetized initially with
2% isoﬂurane, and then at 1% during the examination. Left ventricular short-axis
dimensions at the tip of the papillary muscles were measured on M-mode.
Fractional shortening was calculated as (LVDd–LVDs)/LVDd 100 (%).
Blood pressure measurement. Chronic measurements of blood pressure and
ECG were performed on unrestrained, conscious mice (10-week-old, male) using a
commercially available telemetry and computer-based data acquisition system
(Data Sciences International) according to the manufacturer’s instructions. Brieﬂy,
a pressure-sensing catheter was implanted in the thoracic aorta via the left carotid
artery, and two electrodes were placed subcutaneously on the right shoulder and
left inguinal region to record lead II ECG under anaesthesia with 2% isoﬂurane
inhalation. Mice were returned to their home cage (placed on top of telemetry
receivers), and blood pressure and ECG were continuously monitored and
recorded.
Administration of IGF-1. Recombinant human IGF-I was purchased from Cell
Science, and diluted with 0.9% NaCl at a concentration of 10mgml 1 and
administered to mice (60 mg per day) by continuous infusion (0.25 ml h 1) using a
mini osmotic pump (Alzert 1002). IGF-1 administration and tamoxifen treatment
were started at the same time. Control mice received vehicle alone.
Neonatal cardiomyocyte culture. Primary cardiomyocyte cultures were prepared
from ventricles of 1-day-old mice by very gentle trypsinization at room tempera-
ture, by a modiﬁcation of preparation methods from rat neonatal heats40. Hearts
were rapidly removed from neonatal TRPV2ﬂox/ﬂox;MerCreMerþ / or TRPV2ﬂox/
ﬂox;MerCreMer / mice anesthetized with an overdose of diethyl ether. The
ventricles were excised, cut into several pieces and washed three times with 10ml
ice-cold phosphate-buffered saline for 1min by gentle shaking. The tissue pieces
were digested three times with 0.06% trypsin in DMEM (8ml) for 8min at 37 C by
gentle agitation. The cell suspension was resuspended in DMEM with 10% fetal calf
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Figure 10 | Role of TRPV2 within the working heart. In wild-type mice, TRPV2 protein (yellow) is located in the intercalated discs (red), which is cyclically
stretched and accompanied by cardiac contractions within the working heart. The mechanical feedback signal transmitted via TRPV2 is crucial for
the maintenance of cardiomyocytes. TRPV2 ablation leads to the disruption of the intercalated disc architecture (red), and disorganization of sarcomere
myoﬁbril proteins at the intercalated discs (orange). These TRPV2-KO myocytes show contractile dysfunction. Therefore, the mortality rate of
TRPV2-KO mice is accelerated. Thus, the mechanical feedback signal within the working heart integrates myocyte structure and function, with TRPV2
playing a pivotal role.
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serum (FCS) to stop trypsinization, and was centrifuged at 14g for 3min. The cell
pellets were resuspended in fresh DMEM containing 10% FCS, and plated on
collagen-coated 24-well dishes at a density of 4 104 cells per well and maintained
in DMEM containing 10% FCS. The formation of myocytes clusters and the
spontaneous synchronized beating were conﬁrmed by inverted microscope
(CKX41, Olympus).
Stretch stimulation of cardiomyocytes. For stretch stimulation of cardiomyo-
cytes, the cell suspension were plated on 1 cm2 collagen-coated poly-
dimethylsiloxane stretch chambers at 2 105 cells per well, and cultured. After
24 h, primary cardiomyocytes were divided into two groups and maintained for up
to 2 days in DMEM containing 10% FCS, with or without tamoxifen
(0.2mMml 1). Membranes were uniformly stretched by 20% for 3 s, using a
computer-controlled stepping motor machine (STB-150, STREX), by a slight
modiﬁcation of cell-stretch culture methods41. One end of the chamber was ﬁrmly
attached to a ﬁxed frame, while the other was attached to a movable frame
connected to a motor-driven shaft. The amplitude and frequency of stretch were
controlled by a programmable microcomputer. The silicon membrane was
uniformly stretched over the whole membrane area, and the lateral thinning did
not exceed 1% at 20% stretch. TRPV2 deﬁciency did not have a discernible impact
on the cardiomyocytes’ ability to adhere to the membrane, although the cell–cell
interfaces with neighbouring myocytes were expanded.
Stretch-induced Ca2þ -transients in newborn cardiomyocytes. Stretch-induced
Ca2þ transients were examined in cardiomyocytes loaded with 2 mM fura-2
acetoxymethyl ester (fura-2) for 30min at 37 C and maintained in standard
Tyrode’s solution under continuous ﬂow using a microperfusion system. Fura-2-
loaded cells were alternately excited at 340 and 380 nm using a Lambda DG-4 Ultra
High Speed Wavelength Switcher (Sutter Instruments) coupled to an inverted IX71
microscope with a UApo 20 /0.75 objective lens (Olympus). Fura-2 ﬂuorescent
signals were recorded (ORCA-Flash 2.8; Hamamatsu Photonics) and analysed by a
ratiometric ﬂuorescence method using MetaFluor software (version 7.7.5.0;
Molecular Devices).
Isolation of adult mouse ventricular myocytes. Ventricular myocytes were
obtained from 10-week-old male TRPV2ﬂox/ﬂox;MerCreMerþ / and TRPV2ﬂox/
ﬂox;MerCreMer / mice by a slight modiﬁcation of Shioya’s methods42. Hearts
were rapidly removed from adult TRPV2ﬂox/ﬂox;MerCreMerþ / or TRPV2ﬂox/ﬂox;
MerCreMer / mice anesthetized with an overdose of pentobarbital
(300mg kg 1, intraperitoneally), and Langendorff perfused at a constant
hydrostatic pressure of 70 cm H2O at 37 C using cell isolation buffer (CIB)
supplemented with 0.4mM EGTA (EGTA–CIB), which chelates calcium within the
heart. CIB contained 130mM NaCl, 5.4mM KCl, 0.5mM MgCl2, 0.33mM
NaH2PO4, 22mM glucose, 50 nMml 1 bovine insulin (Sigma) and 25 HEPES-
NaOH (pH¼ 7.4). Insulin was used from 1Uml 1 stock solution in 0.1mM HCl
(pH¼ 4.0). EGTA was from 400mM stock in 1M NaOH (pH¼ 7.8). The perfusate
was then switched to the enzyme solution (15ml), which was CIB supplemented
with 0.3mM CaCl2, 1mgml 1 collagenase (Worthington Biochemical),
0.06mgml 1 trypsin (Sigma) and 0.06mgml 1 protease (Sigma). Once the tissue
had undergone complete digestion, the ventricles were excised, cut into several
pieces and further digested in fresh enzyme solution (15ml) for 15–20min at 37 C
until they were mostly dissociated. In this enzyme solution, the CaCl2 level was
increased to 0.7mM, and 2mgml 1 BSA (Sigma) was supplemented. The cell
suspension was centrifuged at 14g for 3min. The cell pellet (B0.1ml) was
resuspended in CIB supplemented with 1.2mM CaCl2 and 2mgml 1 BSA, and
then incubated at 37 C for 10min, centrifuged (14g, 3min) and resuspended in
10ml Tyroad solution supplemented with 2mgml 1 BSA. Tyrode’s solution
contained 140mM NaCl, 5.4mM KCl, 1.8mM CaCl2, 0.5mM MgCl2, 0.33mM
NaH2PO4, 11mM glucose and 5mM HEPES-NaOH (pH¼ 7.4)40,42.
Cell shortening and Ca2þ transients in adult cardiomyocytes. Isolated cardi-
omyocytes were loaded with 10 mmol l 1 Indo-1 AM (Invitrogen) and electrically
stimulated at 1Hz using a two-platinum electrode insert connected to a bipolar
stimulator (Nihon Kohden, SEN-3301) on the stage of an inverted microscope
(IX71, Olympus) with a  20 water immersion objective lens (UApo N340,
Olympus). Calcium transients were measured as the ratio of ﬂuorescence emitted at
405/480 nm after excitation at 340 nm using a high-performance Evolve EMCCD
camera (Photometrics). Cardiomyocytes were maintained under continuous ﬂow
in standard Tyrode’s solution, exchanged using a microperfusion system. For
measuring caffeine-induced calcium transients, cells were paced at 1Hz prior to
induction of caffeine contractures. Electrical stimulation was stopped 15 s before
rapid perfusion with a 10mmol l 1 caffeine solution. The experiments were
recorded and analysed using MetaMorph software (version 7.7.1.0; Molecular
Devices). Results were the means of the ﬂuorescent signals from 10–20 cardio-
myocytes from a single heart.
Measure of IGF-1 concentration. IGF-1 concentrations were measured in con-
ditioned media from stretched and unstretched myocytes in a sandwich ELISA
using mouse standards, according to the manufacturer’s guidelines (R&D Systems),
which quotes the sensitivity of this assay as 30 ngml 1. Standard curves and
positive controls were included in each assay, and IGF-1 concentrations were
obtained by interpolation.
Real-time PCR. The Mouse PI3K-AKT Signalling Pathway RT2 Proﬁler PCR
Array was purchased from Qiagen. Total RNA extracted from TRPV2ﬂox/ﬂox;
MerCreMerþ / or TRPV2ﬂox/ﬂox;MerCreMer / hearts with or without
tamoxifen were reverse transcribed into cDNA with oligo (dT) primers using
Superpscript III. Real-time PCR was performed with Step-One plusTM (Applied
Biosystem). Statistical analysis of the results was performed with the DCt value
(Ct gene of interestCt b-actin). Relative gene expression was obtained using the DDCt
method (Ct sampleCt calibrator) using the TRPV2ﬂox/ﬂox;MerCreMer / hearts
without tamoxifen as a calibrator.
Histology. Hearts were excised and immediately ﬁxed in buffered 4% paraf-
ormaldehyde, embedded in parafﬁn and sectioned to a thickness of 4 mm. We
stained serial sections of samples with Masson’s trichrome to evaluate gross
morphology and ﬁbrosis. The preparations were examined under a light micro-
scope (SZX7 or BX43, Olympus).
Electron microscopy. For electron microscopy, excised hearts were ﬁxed in 2%
paraformaldehyde/2% glutaraldehyde in 0.1M phosphate buffer, postﬁxed with 2%
OsO4 in 0.1M phosphate buffer and stained with uranyl acetate and lead citrate.
The microtome sections were examined under a JEM-1200 electron microscope
(Nihondensi Co., Japan).
Antibodies. The following antibodies were used for immunostaining or immu-
noblot analysis: anti-TRPV2 (1:200 dilution, AB5398, Millipore); anti-vinculin
(1:100 dilution, V9131, Sigma); anti-connexin 43 (1:100 dilution, C6219, Sigma);
anti-N-cadherin (1:100 dilution, 3B9, life technologies); anti-Cav3 (1:1,000 dilu-
tion, 610420, BD Pharmingen,); anti-LTCC (1:1,000 dilution, ACC033, Alomone);
anti-SERCA (1:1,000 dilution, MA3919, Thermo); and anti-RyR (1:1,000 dilution,
MA3916, Thermo). The anti-NCX antibody was generated in our laboratory
(1:1,000 dilution).
Immunocytochemistry. For immunocytochemistry, 5 mm frozen heart sections
embedded in OCT compound (Tissue-Tek) were permeabilized with 0.1% Triton
X-100 and incubated with primary antibodies. For immunostaining of rat cardi-
omyocytes, cells immobilized on collagen-coated glass slides were ﬁxed with 4%
paraformaldehyde for 15min at room temperature, permeabilized with 0.1% Triton
X-100 and then stained with primary antibodies.These samples were then treated
with Alexa Flour 488-conjugated anti-rabbit IgG (A11008, Life Technologies) or
Alexa Flour 488-conjugated anti-mouse IgG (A11001, Life Technologies). Cells or
secrions were examined using a confocal microscope (Fluoview FV1000, Olympus)
mounted on an Olympus IX81 epiﬂuorescence microscope with a UPlanSApo
 60/1.35 oil immersion objective lens (Olympus).
Immunoblotting. Mice hearts and kidneys were homogenized in a Hiscotron
homogenizer (NITI-ON) in lysis buffer containing 20mM HEPES (pH 7.4),
150mM NaCl, 1% sodium deoxycholate, 1% SDS, 2 mgml 1 leupeptin, 1 mgml 1
aprotinin, 200 mM phenylmethylsulfonyl ﬂuoride, and 200 mM benzamidine
hydrochloride. The lysates were centrifuged at 100,000 g for 20min and the
supernatants were used for immunoblot analysis. Immunoreactive bands were
visualized using a chemiluminescence detection system (Perkin Elmer) and an
LAS3000 Luminescent Image Analyzer (Fuji Film).
Data analysis. Data were analysed by individuals who were blinded to the
genotype, drug treatment or operation. Data presented here were reproducible in at
least three independent experiments. Results are shown as the mean±s.e.m. Paired
data were evaluated using a Student’s t-test. Two-way analysis of variance with
Bonferroni’s post hoc test was used for multiple comparisons wherever appropriate.
The Kaplan–Meier method with a log-rank test was used for survival analysis.
Po0.05 was considered statistically signiﬁcant.
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